| Pharmaceutical active ingredients: |
| Estrogens ConjugatedMedroxyprogesterone Acetate |
| Available forms, composition and doses of Repogen Conti: |
| N / A |
| Repogen Conti medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA57 - Conjugated EstrogensG03FA12 - Medroxyprogesterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Libbs Farmaceutica |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Profemina MP | Estrogens Conjugated; Medroxyprogesterone Acetate | Chile Laboratorios |
| Provelle | Estrogens Conjugated; Medroxyprogesterone Acetate | Pfizer |
| Provette Continuous | Estrogens Conjugated; Medroxyprogesterone Acetate | Pfizer |
| Provette Sequential | Estrogens Conjugated; Medroxyprogesterone Acetate | Pfizer |
| Repogen Ciclo | Estrogens Conjugated; Medroxyprogesterone Acetate | Libbs Farmaceutica |
| Selecta | Estrogens Conjugated; Medroxyprogesterone Acetate | Libbs Farmaceutica |
| Sequennia | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Milprem | Estrogens Conjugated; Meprobamate | MedPointe Healthcare |
| PMB 200 | Estrogens Conjugated; Meprobamate | Wyeth |
| PMB 400 | Estrogens Conjugated; Meprobamate | Wyeth |